EUVIMEDEUVIMED entdecken
Crossref

Impact of long‐term statin therapy on age‐related macular degeneration: A nationwide population‐based study

Po-Yu Jay Chen iD, Jyun-Lin Lee iD, Lei Wan iD, Hui-Ju Lin iD, Wen-Lu Chen, San-Ni Chen, Chun-Ju Lin, Jane-Ming Lin, Chun-Ting Lai, Ning-Yi Hsia, Yu-Te Huang, Yi-Yu Tsai und 6 weitere

British Journal of Clinical Pharmacology · 2025-10 · 91 (10) · 2946-2956

DOI: 10.1002/bcp.70128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 10.06.2025. Verfasst von Po-Yu Jay Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Macular Degeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: China Medical University Hospital, Taiwan Ministry of Health and Welfare Clinical Trial Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Age‐related macular degeneration (AMD) is a leading cause of vision loss worldwide among older adults. Although some studies propose that statins could reduce AMD risk and progression, others report conflicting findings. This study aimed to evaluate the impact of statin use on the incidence of AMD.

Methods

This study used Taiwan's National Health Insurance Research Database (2000–2021) with the LGTD2000 cohort. Participants were categorized into statin users (≥6 months, 2001–2020) and nonusers. AMD incidence was analysed using Cox regression and Kaplan–Meier methods, with propensity score matching applied to report adjusted hazard ratios (AHRs) and confidence intervals (CIs).

Results

After adjusting for confounding factors, statin use for over 2 years was associated with a significantly lower risk of AMD compared to nonstatin users (AHR = 0.79, 95% CI: 0.69–0.91). Subgroup analyses demonstrated that long‐term statin use (≥730 days) showed protective associations across most sex and age groups. Specifically, risk reduction was observed for both non‐neovascular AMD (AHR = 0.84, 95% CI: 0.70–1.02) and neovascular AMD (AHR = 0.72, 95% CI: 0.59–0.88). Furthermore, dose–response analysis revealed that higher cumulative statin exposure was associated with a decreased AMD risk, while lower cumulative exposure was associated with an increased risk.

Conclusion

This study indicated that prolonged statin use exceeding 2 years was associated with a significantly decreased risk of developing both non‐neovascular and neovascular AMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsMacular DegenerationHumansMaleFemaleTaiwanAgedIncidenceMiddle AgedDatabases, FactualAged, 80 and overTime FactorsRisk FactorsKaplan-Meier EstimateProportional Hazards Models

Stichwörter der Autor:innen

age‐related macular degeneration (AMD)neovascular AMDnon‐neovascular AMDstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Eye Center, China Medical University Hospital, Taichung, Taiwan.
  • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
  • Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan.
  • Department of Ophthalmology and Department of Molecular Genetics, China Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
  • Department of Optometry, Asia University, Taichung, Taiwan.

ORCID-Profile: Po-Yu Jay Chen, Jyun-Lin Lee, Lei Wan, Hui-Ju Lin, Yih-Dih Cheng, Peng-Tai Tien

Förderung

  • China Medical University Hospital
  • Taiwan Ministry of Health and Welfare Clinical Trial Center

Zitieren

APA

Chen, P. J., Lee, J. L., Wan, L., Lin, H. J., Chen, W. L., Chen, S. N., Lin, C. J., Lin, J. M., Lai, C. T., Hsia, N. Y., Huang, Y. T., Tsai, Y. Y., Lin, H. J., Hsieh, Y. W., Cheng, Y. D., Tsai, F. J., Chou, C. C., & Tien, P. T. (2025). Impact of long‐term statin therapy on age‐related macular degeneration: A nationwide population‐based study. British Journal of Clinical Pharmacology, 91(10), 2946-2956. https://doi.org/10.1002/bcp.70128

Vancouver

Chen PJ, Lee JL, Wan L, Lin HJ, Chen WL, Chen SN, et al. Impact of long‐term statin therapy on age‐related macular degeneration: A nationwide population‐based study. British Journal of Clinical Pharmacology. 2025;91(10):2946-2956. doi:10.1002/bcp.70128

BibTeX
@article{Chen2025,
  author = {Chen, Po-Yu Jay and Lee, Jyun-Lin and Wan, Lei and Lin, Hui-Ju and Chen, Wen-Lu and Chen, San-Ni and Lin, Chun-Ju and Lin, Jane-Ming and Lai, Chun-Ting and Hsia, Ning-Yi and Huang, Yu-Te and Tsai, Yi-Yu and Lin, Heng-Jun and Hsieh, Yow-Wen and Cheng, Yih-Dih and Tsai, Fuu-Jen and Chou, Chien-Chih and Tien, Peng-Tai},
  title = {Impact of long‐term statin therapy on age‐related macular degeneration: A nationwide population‐based study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {10},
  pages = {2946--2956},
  doi = {10.1002/bcp.70128}
}
Kostenlos starten →